Idiopathic pulmonary fibrosis: Natural history and prognosis

Clinics in Chest Medicine

Volumn 27, Issue SUPPL., 2006, Pages

  Noble, Paul W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; GAMMA1B INTERFERON;

ARTERIAL GAS; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; DYSPNEA; FIBROBLAST; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG CAPACITY; LUNG FUNCTION TEST; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SURVIVAL TIME;

HUMANS; PROGNOSIS; PULMONARY FIBROSIS; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 33644985711     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.08.003     Document Type: Review

References (22)

1. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2000 646 664
2. American Thoracic Society European Respiratory Society American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias Am J Respir Crit Care Med 165 2002 277 304
3. D.B. Coultas, R.E. Zumwalt, and W.C. Black The epidemiology of interstitial lung disease Am J Respir Crit Care Med 150 1994 967 972
4. M.J. Thomeer, U. Costabel, and G. Rizzato Comparison of registries of interstitial lung diseases in three European countries Eur Respir J 18 Suppl 32 2001 S114 S118
5. M. Turner-Warwick, B. Burrows, and A. Johnson Cryptogenic fibrosing alveolitis: clinical features and their influence on survival Thorax 35 1980 171 180
6. D.A. Schwartz, R.A. Helmers, and J.R. Galvin Determinants of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 149 1994 450 454
7. S.E. Gay, E.A. Kazerooni, and G.B. Toews Idiopathic pulmonary fibrosis: predicting response to therapy and survival Am J Respir Crit Care Med 157 1998 1063 1072
8. R. Erbes, T. Schaberg, and R. Loddenkemper Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest 111 1997 51 57
9. H.R. Collard, T.E. King Jr, and B.B. Bartelson Changes in clinical and physiological variables predict survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 2003 538 542 [online supplement available at http://www.atsjournals.org. Accessed March 24, 2005]
10. T.E. King Jr, M.I. Schwarz, and K. Brown Idiopathic pulmonary fibrosis. Relationship between histopathologic features and mortality Am J Respir Crit Care Med 164 2001 1025 1032
11. R.M. Cherniack, T.V. Colby, and A. Flint Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis Am Rev Respir Dis 144 1991 892 900
12. A.S. Narayanan, J. Whithey, and A. Souza Effect of gamma-interferon on collagen synthesis by normal and fibrotic human lung fibroblasts Chest 101 1992 1326 1331
13. J.G. Clark, T.F. Dedon, and E.A. Wayner Effects of interferon-gamma on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts J Clin Invest 83 1989 1505 1511
14. R.K. Coker, and G.J. Laurent Pulmonary fibrosis: cytokines in the balance Eur Respir J 11 1998 1218 1221
15. R. Ziesche, E. Hofbauer, and K. Wittmann A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis N Engl J Med 341 1999 1264 1269
16. K. Schroder, P.J. Hertzog, and T. Ravasi Interferon-gamma: an overview of signals, mechanisms and functions J Leukoc Biol 75 2004 163 189
17. G. Raghu, K.K. Brown, and W.Z. Bradford A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis N Engl J Med 350 2004 125 133
18. T.E. King Jr, S. Safrin, and K.M. Starko Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis Chest 127 2005 171 177
19. A.L.A. Katzenstein, and J.L. Myers Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification Am J Respir Crit Care Med 157 1998 1301 1315
20. P.W. Noble, and R.J. Homer Idiopathic pulmonary fibrosis: new insights into pathogenesis Clin Chest Med 25 2004 749 758
21. P.W. Noble, and D.G. Morris Time will tell: predicting survival in idiopathic interstitial pneumonia Am J Respir Crit Care Med 168 2003 531 537
22. F.J. Martinez, S. Safrin, and D. Weycker The clinical course of patients with idiopathic pulmonary fibrosis Ann Intern Med 142 2005 963 967